Literature DB >> 18563483

Continuing debate on D2 lymphadenectomy for gastric cancer.

Dimosthenis Ziogas1, George Baltogiannis, Michael Fatouros.   

Abstract

Entities:  

Mesh：

Year:  2008        PMID： 18563483     DOI： 10.1007/s00268-008-9645-2

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  34 in total

1.  Extended (D2) lymph node dissection for gastric cancer: do patients benefit?

Authors:  D H Roukos
Journal:  Ann Surg Oncol       Date:  2000-05       Impact factor: 5.344

2.  Approaching the dilemma between prophylactic bilateral mastectomy or oophorectomy for breast and ovarian cancer prevention in carriers of BRCA1 or BRCA2 mutations.

Authors:  Dimitrios H Roukos; Niki J Agnanti; Evangelos Paraskevaidis; Angelos M Kappas
Journal:  Ann Surg Oncol       Date:  2002-12       Impact factor: 5.344

3.  Role of surgery in the prophylaxis of hereditary cancer syndromes.

Authors:  Dimitrios H Roukos; Aggelos M Kappas; Epameinondas Tsianos
Journal:  Ann Surg Oncol       Date:  2002-08       Impact factor: 5.344

4.  Preventing breast, ovarian cancer in BRCA carriers: rational of prophylactic surgery and promises of surveillance.

Authors:  Niki J Agnantis; Evangelos Paraskevaidis; Dimitrios Roukos
Journal:  Ann Surg Oncol       Date:  2004-11-15       Impact factor: 5.344

5.  Nodal dissection for patients with gastric cancer: a randomised controlled trial.

Authors:  Chew-Wun Wu; Chao A Hsiung; Su-Shun Lo; Mao-Chin Hsieh; Jen-Hao Chen; Anna Fen-Yau Li; Wing-Yiu Lui; Jacqueline Whang-Peng
Journal:  Lancet Oncol       Date:  2006-04       Impact factor: 41.316

6.  Prognosis of breast cancer in carriers of BRCA1 and BRCA2 mutations.

Authors:  Dimitrios H Roukos
Journal:  N Engl J Med       Date:  2007-10-11       Impact factor: 91.245

7.  Level I evidence in support of perioperative chemotherapy for operable gastric cancer: sufficient for wide clinical use?

Authors:  Evangelos Briasoulis; Michael Fatouros; Dimitrios H Roukos
Journal:  Ann Surg Oncol       Date:  2007-07-26       Impact factor: 5.344

8.  HER2 and response to paclitaxel in node-positive breast cancer.

Authors:  Dimitrios H Roukos
Journal:  N Engl J Med       Date:  2008-01-10       Impact factor: 91.245

Review 9.  Extended lymphadenectomy in gastric cancer: when, for whom and why.

Authors:  D H Roukos
Journal:  Ann R Coll Surg Engl       Date:  1998-01       Impact factor: 1.891

10.  Prognostic factors and availability of D2 lymph node dissection for the patients with stage II gastric cancer: comparative analysis of subgroups in stage II.

Authors:  Joong-Min Park; Jong-Han Kim; Sung-Soo Park; Seung-Joo Kim; Young-Jae Mok; Chong-Suk Kim
Journal:  World J Surg       Date:  2008-06       Impact factor: 3.352
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.